Hot Features
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/l... Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.6 | 37.5 | 1.6 | 2.215 | 1.544 | 224614 | 1.77747597 | CS |
| 4 | 0.01 | 0.456621004566 | 2.19 | 2.2791 | 1.5006 | 159990 | 1.7512399 | CS |
| 12 | -0.28 | -11.2903225806 | 2.48 | 3 | 1.5006 | 102319 | 2.03587742 | CS |
| 26 | -0.97 | -30.5993690852 | 3.17 | 5.35 | 1.43 | 270891 | 2.70481821 | CS |
| 52 | -7.07 | -76.2675296656 | 9.27 | 67 | 1.43 | 392666 | 16.14258971 | CS |
| 156 | -5.91 | -72.8729963009 | 8.11 | 67 | 1.43 | 386874 | 16.07487612 | CS |
| 260 | -5.91 | -72.8729963009 | 8.11 | 67 | 1.43 | 386874 | 16.07487612 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.